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Abstract
With its increasing incidence in younger population and as a leading cause of 
disability, ischemic stroke represents a real public health problem. This chapter aims 
to evaluate the most common risk factors and causes for ischemic stroke in the young. 
Though some are identical to those found in older patients, most of them are specific to 
this population segment. Furthermore, another objective is to provide some guidance in 
approaching the case based on some important clinical clues. Due to the lack of univer-
sal management guidelines, it is up to the physician to judge the particularities of each 
case and to carry out the variety of investigations necessary for determining the cause.
Keywords: ischemic stroke, young adults, risk factors, etiology, diagnosis guide
1. Introduction
Contrary to the general opinion that it is a disease of the elderly, ischemic stroke 
is a condition that can occur at any age. Of course, its incidence increases with age, 
but it has been observed to increasingly affect young people. This tendency can have 
multiple consequences. Since it targets the young working population, economic 
and social burden are known to appear.
Although some of the causes or risk factors of ischemic stroke are common for 
both young and elderly patients, they do not overlap. In young people, the causes 
can be multiple: heart, vascular, or genetic disorders that require further, some-
times complex investigations. In addition, most cryptogenic strokes appear in this 
age category. The classic cardiovascular risk factors, which are in present much 
more prevalent at much younger ages, should also be taken into account.
This chapter aims to illustrate the most frequent causes of ischemic stroke in 
young people and its associated risk factors and to provide some guidance regarding 
further investigations necessary for determining the cause.
2. Ischemic stroke in young adults
2.1 Epidemiology
Stroke represents a common cause of morbidity and mortality worldwide. It 
has been estimated that more than 11 million patients are diagnosed with ischemic 
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stroke each year [1]. The incidence of stroke varies by geographical area and also by 
sex, age, and race. Although stroke has been previously considered a disease that 
is mostly affecting the older population, recent publications show that between 
10 and 15% of the total number of strokes occur in younger patients [2]. This 
means that each year, approximately 2 million adolescents and young adults across 
the world suffer from an ischemic stroke [3]. Furthermore, recent epidemiologi-
cal studies have shown that since the 1980s, the incidence of ischemic stroke in 
the young population has increased, while its incidence in the elderly group has 
declined. This result raises a few concerns regarding its socioeconomic impact. It 
occurs in young people with long-life spans ahead, during their most productive 
years, and causes major long-term disability, with great health-care costs [4]. Some 
possible explanations for this trend are: improved population awareness regarding 
stroke symptoms, improved diagnosis performance using advanced neuroimaging 
techniques, or an increment in the prevalence of the known risk factors (type 2 
diabetes, obesity, lack of physical activity, and recreational drug use).
An important question is how is this “young stroke” group defined? Which 
are its cut-off limits? The majority of authors are using the age of 45 as the group’s 
upper limit [5]. Others favor the age of 49 [2]. This age limit has been arbitrarily 
drawn based on the major differences in etiologies and risk factors between these 
two age groups [1].
It has been found that the incidence rate of stroke grows with age, being at its 
highest in the 45–49 age interval and at its lowest in the group of patients younger 
than 35 [4].
Incidence rates vary also from a geographical perspective. Developing countries 
report a higher incidence rate than industrialized ones [1]. Asian countries such 
as Japan and Taiwan also report higher rates [5]. The “young stroke” incidence is 
also higher among American blacks and Hispanics. In addition, it has been stated 
that the hospital stay was longer and mortality higher in black population versus 
Caucasian [1].
Looking at sex differences, the incidence appears to be higher in men than in 
women, though some studies have shown that before the age of 30 the incidence of 
“young stroke” is higher in women [5]. Men have exhibited a higher mortality rate 
and risk for reoccurring vascular events [1].
2.2 Pathophysiology of ischemic stroke
An ischemic stroke occurs due to a decreased blood flow in a certain area in the 
brain. This can be the consequences of obstruction of one of the blood vessels that 
irrigates the brain, or it can occur due to low systemic blood pressure. The most 
common causes of blood vessel obstruction are thrombosis and embolization. 
Thrombosis usually develops on atherosclerotic plaques. Atherosclerotic plaques 
tend to form in larger arteries and are responsible for narrowing the vascular lumen. 
The process can even lead to the complete occlusion of the blood vessel. The blood 
clot can embolize distally, causing an ischemic stroke. Though rarely, in situ throm-
bosis can also occur due to an underlying hematological abnormality (leukemia and 
polycythemia). Other causes of arterial obstruction are arteritis, arterial dissection, 
and arteriolosclerosis. Distal embolization is another common mechanism. Most 
commonly, the source is cardiac. When the source of emboli is in the venous system 
of the members, the correct term is paradoxical embolization.
When discussing the pathophysiology of ischemic stroke, we most often refer 
to arterial stroke [6]. Cerebral blood flow (CBF) represents the ratio of cerebral 
blood volume (CBV) to mean transit time (MTT). There is a directly proportional 
relationship between CBF reduction and the size of the stroke. Narrowing the vessel 
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caliber, MTT increases and CBF decreases. To minimize the reduction in blood flow, 
autoregulation mechanisms start to intervene. Distally to the site of occlusion or 
stenosis, vasodilation appears, and in addition, the oxygen extraction rate increases. 
These initial measures help maintain normal perfusion. CBF of 50 ml/100 g brain 
tissue/min represents the adequate cerebral blood supply. In the ischemic penum-
bra, FSC is somewhere between 10 and 30 ml/100 g brain tissue/min. The nerve 
cells in this area can be saved in the first hours after symptoms onset by methods of 
recanalization of the affected vessel. When FSC drops below 10 ml/100 g of brain 
tissue, necrosis occurs. The nerve cells in the necrotized area can, at this point, no 
longer be recovered. ATP depletion, high extracellular K levels, high intracellular 
Ca levels, cellular acidosis, phospholipases activation, intracellular enzymes, and 
structural protein alteration eventually lead to cytotoxic edema and cell death. 
Neural losses are irreversible and begin in the first 4–8 minutes after the onset of 
ischemia, in the absence of collateral circulation to supplement the cerebral blood 
flow. In every minute of ischemia, 1.9 million neurons, 14 million synapses, and 
12 km of myelin fibers are lost [7].
However, a small fraction of ischemic strokes is caused by venous blood flow 
abnormalities. Intracranial venous occlusion can cause hemorrhages and compres-
sions and can lead to ischemia [6].
2.3 Risk factors
Conventional cardiovascular risk factors, for instance, hypertension, diabe-
tes, and dyslipidemia, are considered important risk factors for all adults. Their 
prevalence among the young has been increasing over the last 10 years. Studies 
show that the most common risk factors found among young stroke patients are: 
smoking (56%), physical inactivity (48%), hypertension (47%), and dyslipidemia 
(35%) [2, 4]. On the other hand, among the elderly, the most prevalent ones are 
hypertension, diabetes, and cardiac diseases such as atrial fibrillation [8]. The 
tendency toward obesity, the lack of physical activity, the rising number of smok-
ers, and heavy episodic alcohol consumption among teenagers and young adults, 
which have all been linked to a higher ischemic stroke incidence, are, indeed, 
worrisome [1].
An interesting observation is that young patients with no vascular risk factors 
have lower mortality associated with the stroke and fewer recurrences. This means 
that the number of vascular risk factors can be regarded as an important prognostic 
factor to determine clinical outcome [8].
Drug use is another important risk factor. It is believed that roughly 5% of the 
population aged 15–64 use illicit or recreational drugs at least once a year. Such sub-
stances associated with ischemic stroke are cocaine, amphetamine, cannabis, and 
opioids. The negative effects of these substances can be explained either through 
their direct effects on the cardiovascular system or through complications linked 
to their administration pathway (embolism or endocarditis related to intravenous 
administration). The negative effects on cardiovascular system include cardiomy-
opathies, cardiac arrhythmias, orthostatic hypotension, vasoconstriction, platelet 
aggregation, accelerated atherosclerosis, and vasculitis. Though previously thought 
harmless, cannabis consumption can possibly lead to reversible cerebral vasocon-
striction syndrome and intimal hyperplasia [3, 8].
Pregnancy and the puerperium are also associated with an elevated risk for 
ischemic events. Although considered a somewhat scarce occurrence, ischemic 
strokes associated with pregnancy carry higher mortality rates. The risk is at its 
highest from the third trimester until 6 weeks postpartum [9]. In countries like 
India and Mexico, pregnancy-related stroke is not that uncommon and is caused by 
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dural sinus thrombosis [10]. Causes of ischemic stroke in this category of patients 
are peripartum cardiomyopathy, hypercoagulability associated with pregnancy, 
postpartum cerebral angiopathy (reversible cerebral vasoconstriction syndrome), 
amniotic fluid embolism, or trophoblastic embolism due to choriocarcinoma [9]. 
Ischemic stroke during pregnancy is also linked to other pregnancy-related com-
plications, as the mechanisms appear to be similar [3]. Special attention should be 
given to peripartum cerebral venous thrombosis. Risk factors are anemia, first time 
carrying a pregnancy, and lack of medical care during pregnancy. Frequent signs 
and symptoms at presentation for patients with this condition are headache, altered 
consciousness, and motor deficit. Papilledema is observed in up to 80% of patients. 
Treatment includes anticoagulation, and sometimes, anticonvulsant therapy is also 
necessary. Prognosis is usually favorable [11].
Contraceptive use raises the risk of ischemic stroke, even more so if associ-
ated with smoking or migraines with aura. The risk is tightly linked to the estrogen 
content in the pill. Progesterone contraceptives do not pose any threat [5, 8].
Migraine with aura appears to be linked to ischemic stroke, especially if tied 
with other risk factors such as smoking and use of oral estrogen contraceptives. The 
association is, though, quite controversial [2, 3]. The mechanism is still not known. 
Its involvement as a risk factor is more evident in young women [5].
Malignancy, along with chemotherapy and radiotherapy, can increase the risk 
of ischemic stroke, through various mechanisms: direct vessel compression, tumor 
embolism, nonbacterial thrombotic endocarditis, hypercoagulability, and acceler-
ated atherosclerosis. Current guidelines offer no information regarding cancer 
screening in young patients presenting for stroke [3].
2.4 Etiology
2.4.1 Cardiac causes
Cardiac embolism is responsible for almost 30% of ischemic strokes in young 
adults [8]. The most frequent causes of cardiac embolism are presented in Table 1.
Although regarded as a frequent risk factor in the elderly, atrial fibrillation is not 
as prevalent in the young [2]. Due to its paroxysmal occurrence, it is also relatively 
difficult to diagnose, and it requires continuous monitoring, which is not always 
justified in younger patients with no cardiac pathology. Other electrocardiographic 
abnormalities regarding the P-wave have also been associated with higher risk for 
ischemic stroke [3, 8]. Due to rheumatic heart disease, mitral valve disease should 
be considered as a potential cause of ischemic stroke in the young. Its prevalence is 
higher in less industrialized geographic areas [5].
Cardiomyopathies, though rare, should also be considered. Dilated cardiomy-
opathy is linked to alcohol consumption and occurs at younger age. Chagas disease 
is more frequent in South America [5]. HIV-associated cardiomyopathy has also 
been cited as a possible etiology [12]. Peripartum cardiomyopathy is frequent in 
sub-Saharan Africa. In this case, an echocardiography can help identify the source 
of emboli [3]. An echocardiography can also identify a cardiac tumor as a source 
of emboli, such as an atrial myxoma or a papillary fibroelastoma. Atrial myxoma 
is the most common type of cardiac tumor. It is usually asymptomatic and only 
discovered after an ischemic stroke. Ischemic stroke can also be a complication of 
infectious or thrombotic nonbacterial endocarditis. Infectious endocarditis should 
be suspected particularly if the patient is an intravenous drug user. Thrombosis due 
to acute myocardial infarction or congestive heart failure is not common causes in 
young-related ischemic stroke [13]. Patent foramen ovale is a frequent congenital 
anomaly, found in over 20% of the population. Its prevalence in stroke patients 
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younger than 50 years old is even higher, up to 50%, but its direct role as a causative 
agent is still debated [8]. Patent foramen ovale is not solely responsible for such 
consequences, and it also requires other contributing factors such as the simultane-
ous presence of an atrial septal aneurysm, at rest right to left shunt, larger shunt. 
Furthermore, additional risk factors for venous thrombosis should be present: 
prolonged immobilization, long distance travel, varicose veins, trauma, or pro-
thrombotic conditions [4].
To determine whether PFO was the main mechanism in patients with stroke, it is 
useful to calculate the Risk of Paradoxical Embolism (RoPE) score [14].
The RoPE score (Table 2) ranges between 0 and 10 points. A higher score 
indicates a strong possibility that PFO is the causative agent, while a lower score 
suggests that PFO could only be an incidental find (Figure 1) [4]. RoPE score can 
also predict the risk of recurrence. A patient with a high RoPE score is a young 
patient with very few to almost no cardiovascular risk factor and, as a consequence, 
a very low short-term recurrence risk [3].
2.4.2 Nonatherosclerotic, noninflammatory angiopathies
Cervicocephalic arterial dissection is the origin of ischemic stroke in young 
patients in 20% of the cases. It affects men in a larger proportion than women 
(52–69%) [15]. It refers to the intramural hemorrhage of the extracranial arterial 
segments. The vertebral artery and the internal carotid artery are affected in 90% 
of the cases [16]. Their cervical extracranial segments are most susceptible to dis-
section due to their mobility and close proximity to adjacent bone structures such as 
the transverse processes of the cervical vertebrae. The site of dissection is different 
than the segment usually affected by the process of atherosclerosis. While athero-
sclerosis usually develops at the origin of the internal carotid artery, the arterial 
segments prone to dissection are the distal cervical segments of the internal carotid 
artery. The vertebral artery, more mobile and prone to injury, is also most affected 
at its distal extracranial segment, the V3 segment [15, 17].
As a result of a tear in the intimal layer of the vessel, an intramural hematoma 
will appear. The blood then further extends superiorly along the longitudinal 
axis of the blood vessel. The hematoma develops between the layers of the media, 
but if it is situated between the intimal layer and media, the dissection is called 
subintimal. This type of dissections will most likely narrow the arterial lumen and 
cause stenosis or even full occlusion of the artery. However, if the blood enters 
between the tunica media and the adventitia, a dissection aneurysm will occur. This 
type of dissection is called subadventitial. In this type of dissection, the arterial 
lumen is not narrowed, and it actually appears widened and can compress adjacent 
Cardioembolic cause
Lower prevalence Higher prevalence
Atrial fibrillation Congenital cardiac anomalies
• Patent foramen ovale
• Atrial septal aneurysms
Nonrheumatic valvular disease Cardiomyopathies
Acute myocardial infarction Rheumatic valvular disease
Cardiac tumors Endocarditis
Table 1. 
Cardioembolic causes of stroke in the young.
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Figure 1. 
Pathway to determining etiology of ischemic stroke in patients with PFO.
structures such as sympathetic nerves or the hypoglossal cranial nerve. A blood 
clot typically forms at the segment of artery affected. The thrombus is not firmly 
attached to the intimal layer and can easily embolize distally [15, 16, 18]. Dissection 
of the carotid or vertebral arteries can be accompanied by several signs or symp-
toms. Headache and neck pain are common. Ipsilateral Claude Bernard Horner 
Syndrome can occur due to compression of the hematoma on the adjacent sympa-
thetic nerve fibers. Ipsilateral cranial nerve palsies can also be present. These signs 
can precede the ischemic event with hours or even days in some cases [19].
Predisposing factors to cervicocephalic arterial dissection are: hypertension, 
recent infection, and migraine. Surprisingly, risk factors for atherosclerosis such 
as obesity and dyslipidemia are negatively correlated with cervical arteries dissec-
tion [19].
A cervicocephalic arterial dissection can appear spontaneously (in 60% of the 
cases) or after a recent traumatic event [15]. The traumatic events possibly respon-
sible and other risk factors are illustrated in Table 3.
Furthermore, arterial dissection can occur on a normally structured blood vessel 
or on a vessel affected by an underlying arteriopathy (Table 3).
An ultrasound examination can suggest the presence of arterial dissections, 
but the diagnosis is made through angio-magnetic resonance imaging and angio-
computer tomography.
Angiography, though an invasive procedure, is the most accurate and precise 
diagnostic tool.
Patient information Points
Cortical stroke 1
No hypertension 1
No diabetes 1
No previous stroke or TIA 1
Nonsmoker 1
AGE
18–29 5
30–39 4
40–49 3
50–59 2
60–69 1
>70 0
Total
Table 2. 
RoPE score [14].
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2.4.3 Inflammatory diseases
The term vasculitis groups a series of diseases characterized by inflammation of 
blood vessel walls. Inflammation of blood vessels, possibly accompanied by varying 
degrees of necrosis, can lead to stenosis, vessel occlusion, or aneurysmal dilation. 
Both arteries and veins can be affected, regardless of their size. Vasculitis that 
affects the central nervous system can be either primary or secondary to a systemic 
disorder [19].
Primary angiitis of the central nervous system (PACNS) usually affects small 
vessels (precapillary arterioles). The lesions are multifocal, which makes it difficult 
to diagnose. A normal biopsy does not rule out PACNS. It can affect both brain 
and spinal cord, but no other organs are affected. Its evolution is heterogenic, but 
it usually presents in a recurrent remitting fashion. Sometimes, it can be rapidly 
progressive, leading to exitus in a matter of days [20]. The cause of PACNS is not 
known, but studies show that it is usually associated with other diseases such as 
Hodgkin lymphoma, leukemia, primary intracerebral lymphoma, HIV infection, 
and Varicella Zoster virus infection. Most frequently, the clinical picture includes 
headache and altered cognition, sometimes seizures. Systemic symptoms and signs 
Underlying nonatherosclerotic, noninflammatory arteriopathies
Fibromuscular dysplasia
Moyamoya disease
Type 4 Ehlers-Danlos syndrome
Osteogenesis imperfecta type 1
Pseudoxanthoma elasticum
Autosomal dominant polycystic kidney disease
α1-antitrypsin deficiency
Mechanical trigger factors for cervicocephalic arterial dissection
Major traumatic events Cervical spine fracture
Direct trauma to the anterior neck (punch, 
strangling)
Penetrating lesion of the anterior neck
Sudden and severe rotations of the neck
Minor traumatic events Sports activities (skiing, tennis, and yoga)
Forceful coughing
Vomiting
Nose blowing
Sexual activity
Abnormal, sustained head position
Prolonged head turning
Iatrogenic cause Chiropractic manipulation of the neck
Resuscitation
Anesthesia
Table 3. 
Underlying nonatherosclerotic, noninflammatory arteriopathies and mechanical trigger factors for 
cervicocephalic arterial dissection.
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such as fever, fatigue, weakness, loss of appetite, and weight loss are very rarely 
seen. Blood inflammatory markers such as C-reactive protein and erythrocyte 
sedimentation rate (ESR) are usually normal or slightly elevated. So is blood cell 
count. The cerebrospinal fluid analysis shows signs of inflammation.
Many systemic vasculitides can affect the central nervous system. Some of 
the most common are briefly presented in Table 4. Other causes of noninfectious 
angiitis include drug use, radiotherapy, and neoplasia [20].
When the central nervous system is affected, the clinical picture typically 
includes headaches. Other signs and symptoms that may be suggestive are fever, 
weight loss, dermatological findings (rash and livedo reticularis), articular lesions, 
and kidney disease. The inflammation markers such as C-reactive protein and ESR 
are usually elevated. Other frequent findings in blood tests are anemia, thrombocy-
topenia, and low complement levels. Cerebrospinal fluid also shows increased level 
of proteins and inflammatory cells [19].
In a young patient presenting with ischemic stroke with accompanying sugges-
tive symptoms, a systemic angiitis should be suspected. Determining ANCAs and 
dsDNA antibodies can, in this particular case, be of an important value for deter-
mining an underlying condition causing the stroke (Figure 2) [21].
2.4.4 Infectious diseases
Some infectious diseases are linked through various mechanisms with ischemic 
stroke. Some infectious agents tied to secondary vasculitis are presented in Table 5. 
Infections involved in the pathogenesis can be either viral, bacterial, parasitic, or 
fungal [22].
HIV infections can predispose to stroke through various mechanisms. One 
pathogenic pathway is large vessel HIV arteriopathy. The arteriopathy may be due 
to the direct pathogenic effect of the virus. As a consequence of the vasculopathy, 
large, hemispheric infarctions can appear. Another possible pathogenic pathway is 
through opportunistic infections of the central nervous system, which can occur as 
HIV is responsible for an immunosuppressive state. Such opportunistic infections 
are tuberculosis, Varicella-Zoster virus infection, toxoplasmosis, and syphilis [20].
Tuberculous meningitis is a severe condition with a high mortality rate. Up to 
45% of patients diagnosed with tuberculous meningitis develop a stroke, sometimes 
even multiple strokes [20, 22].
Systemic angiitis affecting the central nervous system
Large-vessel angiitis Takayasu’s disease
Medium-vessel angiitis Polyarteritis nodosa
Kawasaki disease
Small-vessel angiitis ANCA + Eosinophilic granulomatosis with polyangiitis (Churg-Strauss 
syndrome)
Granulomatosis with polyangiitis (Wegener granulomatosis)
Microscopic polyangiitis
Angiitis associated with connective 
tissue disease
Systemic lupus erythematosus
Rheumatoid arthritis
Behçet disease
Table 4. 
Systemic angiitis that affects the central nervous system.
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Among parasitic infections, Chagas disease and cysticercosis are most com-
monly involved. Up to 10% of the patients with neurocysticercosis develop strokes 
(ischemic strokes occur more frequently) [20, 22].
Fungal infections most commonly affect patients who suffer from immunosup-
pression. Ischemic strokes represent an unfortunate complication. Cryptococcus 
infections and aspergillosis are linked to HIV infection [20].
In the present context of Covid-19 pandemic, it is important to emphasize the 
link between the infection and a prothrombotic status. Thrombotic complications 
represent a frequent find in patients infected. For this reason, the risk of ischemic 
strokes should also be taken into consideration [23].
2.4.5 Hematological diseases
A large number of hematological diseases predispose to stroke. The mechanisms 
behind this predisposition are increased blood viscosity, which in return decreases 
blood flow and hypercoagulability. Even though, a single factor cannot by itself be 
the only cause for the ischemic stroke, a combination of such predisposing factors 
can have such unwanted consequences. Some conditions that lead to an increase in 
blood viscosity are leukemia, intravascular lymphoma, sickle cell anemia, erythro-
cytosis, polycythemia vera, Waldenström’s macroglobulinemia, paraproteinemia, 
and spherocytosis. Even though coagulopathies are mostly associated with venous 
thrombosis, recent studies show that deficiency in certain factors involved in blood 
Figure 2. 
Pathway to determine etiology in young patients with ischemic stroke.
Infectious agents linked to secondary vasculitis
Viral infections HIV (AIDS)
Hepatitis B and C
Varicella-Zoster virus infection
Cytomegalovirus infection
Bacterial infections Tuberculosis
Lyme neuroborreliosis
Bacterial meningitis
Syphilis
Mycoplasma pneumoniae infection
Brucellosis
Parasitic infections Cysticercosis
Chagas disease
Trypanosoma cruzi infection
Leptospirosis
Malaria
Fungal infections Cryptococcus infection
Aspergillus infection
Table 5. 
Infectious agents linked to secondary vasculitis [2, 20].
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clotting such as Protein C, Protein S, antithrombin, and Factor V Leiden mutation 
increases the risk of arterial thrombosis [19].
Factor V Leiden mutation is a single point mutation that leads to protein C 
activity resistance. The result is generation of high levels of thrombin, which in turn 
raises the risk for thromboembolic events. Heterozygosity or homozygosity for this 
mutation is usually associated with other hereditary coagulation abnormalities [24].
Prothrombin gene mutation is another frequent hereditary disease that inter-
feres with normal blood coagulation. Patients with prothrombin gene mutation 
have higher than normal levels of prothrombin, which predisposes to thrombosis. 
This condition is associated with cerebral venous thrombosis, especially when there 
is a second risk factor involved, like the use of oral contraceptives [24].
Protein C and Protein S are proteins that inhibit the coagulation cascade. 
Their deficiency predisposes to blood coagulation and can be genetic, or, in some 
cases, acquired. Conditions associated with Protein C and Protein S deficiency 
are contraceptives use, pregnancy, severe infections, liver diseases, disseminated 
intravascular coagulation, and certain medications such as methotrexate and 
cyclophosphamide [24].
Antithrombin III (ATIII) deficiency is a genetic disease inherited in an 
autosomal-dominant pattern. Its prevalence in the population is 0.2%. Its role is to 
inhibit the generation of thrombin. Antithrombin deficiency can also be acquired: 
severe infections, cirrhosis, disseminated intravascular coagulation, and nephrotic 
syndrome [24].
None of the conditions described above (Factor V Leiden mutation, prothrom-
bin gene mutation, Protein C and S deficiency, and ATIII deficiency) can cause, 
by themselves, without additional risk factors, in situ arterial thrombosis. On the 
other hand, Antiphospholipid Antibody Syndrome is known to cause venous, as 
well as arterial thrombosis. Ischemic stroke is a recognized complication of this 
syndrome [24].
2.4.6 Genetic diseases
Family history of stroke at a young age should be suggestive for a genetic cause. 
Many genetic abnormalities have been linked to the possibility of ischemic stroke. 
However, stroke represents the main manifestation in only a few genetic diseases.
Periventricular lesions with predominant temporal pole involvement may 
suggest an autosomal dominant arteriopathy with subcortical infarcts and leu-
koencephalopathy CADASIL, with autosomal dominant transmission. Although 
rare, it is an undiagnosed affliction, so its prevalence may be underestimated. The 
condition is characterized by a mutation in the NOTCH3 gene located on chromo-
some 19. The NOTCH3 gene is expressed almost exclusively in smooth muscle fibers 
and encodes a receptor located at the cell surface. NOTCH3 gene mutation leads to 
smooth muscle degeneration. The condition starts manifesting between the age of 
30 and 60. Patients present with recurrent ischemic strokes, migraine with aura, 
mood swings, and progressive cognitive impairment. Severe leukoaraiosis is seen on 
imagining. Temporal lobes are typically involved [19, 25].
Cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoen-
cephalopathy (CARASIL) is a much rare disease than CADASIL and affects almost 
exclusively the Japanese population. It is characterized by a mutation in HTRA1 
gene, which encodes HtrA serine peptidase/protease 1 (HTRA1). The clinical pic-
ture includes alopecia occurring at young age, low back pain, progressive cognitive 
impairment, and lacunar strokes [19, 26].
CARASAL is another vascular leukoencephalopathy with R325C mutation in 
CTSA gene [27].
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In other genetic diseases, such as Fabry disease or homocystinuria, though 
not considered a representative feature, ischemic stroke is strongly linked. Fabry 
disease has X-linked transmission. It is characterized by a reduced activity of the 
α-galactosidase enzyme, an enzyme involved in lipid metabolism. As a result, 
lysosomal lipid accumulation occurs in endothelial cells and smooth muscle 
fibers of blood vessels. This process can have many unwanted consequences, 
including ischemic stroke. The diagnosis is made by dosing the enzyme value in 
patient’s blood.
Homocystinuria is a genetic disease transmitted in an autosomal recessive 
pattern and characterized by high levels of homocysteine in blood and urine. The 
cause is a deficit in an enzyme called cystathionine β-synthase. The clinical picture 
includes Marfanoid appearance, mental retardation, premature atherosclerosis, and 
thrombembolic events.
MELAS (mitochondrial encephalopathy, lactic acidosis, and stroke-like epi-
sodes) is caused by mutations in mitochondrial DNA. Ischemic strokes appear 
before the age of 40. The occipital lobes are typically affected [26].
2.4.7 Venous ischemic stroke in young
Cerebral venous thrombosis (CVT) is a rare affliction, occurring mostly in the 
younger population. Seventy-five percent of the patients diagnosed with CVT are 
young women [19]. Even though if mostly affects young women, it can occur at any 
age, children and newborns also being affected.
Hormones clearly play a role in the pathophysiology of the disease. Its incidence 
is higher during pregnancy and postpartum (especially in countries such as India 
and Mexico). It is also correlated with oral contraceptive use and other hormonal 
therapies [28].
Other risk factors for CVS are hematological diseases that cause blood hyperco-
agulation and other coagulopathies, infections of the central nervous system, sinus 
and ear infections or other infections occurring in the region of head and neck, and 
severe systemic infections (HIV, tuberculosis, and sepsis). Malignancy, systemic 
inflammatory diseases such as SLE and sarcoidosis and several inflammatory 
angiopathies are also linked to CVT. Other events linked to CVT are head trauma, 
brain surgery, and lumbar punctures [29].
The obstruction of dural venous sinuses or intracerebral veins hinders blood 
drainage and leads to increased pressure above the obstacle. As a result, in the 
affected area of the brain, edema develops. Arterioles and capillaries can break and 
hemorrhage appears. In addition, if the tissue pressure becomes higher than the 
arteriole’s pressure of perfusion, ischemia installs [28].
Transverse sinuses and superior sagittal sinuses are most affected. Sometimes, 
multiple areas in the brain can be affected [19].
The clinical onset is typically gradual, but a sudden onset is also possible. The 
clinical picture includes headache, seizures, focal neurological signs, and altered 
consciousness. A useful sign is the presence of papilledema.
Blood tests show elevated D-dimer levels.
Neuroimaging is the most helpful tool in the diagnosis process. A CT scan can 
visualize parenchymal hemorrhage and tissue edema. Sometimes, the thrombus can 
be seen on imaging as a hyperdense lesion. MRI is an even more sensitive method, 
which can better characterize the abnormalities in the brain parenchyma. It can 
reveal recent infarction, hemorrhage, and tissue edema. These imaging techniques 
also help identify some predisposing factors such as sinusitis, mastoiditis, cerebral 
tumors, or abscesses. They are also extremely useful in the differential diagnosis 
process [28].
Ischemic Stroke
12
CVS is a condition that can now benefit from rapid diagnosis with IRM tech-
niques. When rapidly identified and specific measures applied, the prognosis is 
favorable, the condition having a low mortality rate [19].
Anticoagulation is the therapy of choice, even if imaging also shows hemor-
rhage. Thrombolytic therapy has not proved to be superior to anticoagulation. It 
is used only when anticoagulating agents fail. Sometimes, when the etiology of 
thrombosis is identified, it may require specific treatment. The patient may require 
antibacterial or antiviral therapy, antineoplastic agents. In case of severe cases of 
raised intracranial pressure, decompression techniques may be performed [28].
2.4.8 Cryptogenic stroke
Despite all the diagnostic advances, up to 35% of ischemic strokes, especially in 
young people, have no identified cause [20].
2.5 Diagnosis
For determining the underlying cause of ischemic stroke in the young, certain 
clinical clues can be of great value (Table 6). Depending on the clinical picture, 
routine investigations can be then followed by additional, more specific tests 
(Table 7) [19, 20, 30].
Apart from the usual test in young patients presenting with ischemic stroke 
(complete blood count, blood glucose, hemoglobin a1c, lipid panel, heart enzymes 
CK, troponin, electrocardiogram, liver and kidney function, ESR, CRP, serum elec-
trolytes, PT, INR, APTT, pregnancy test, urine analysis, brain imaging, and chest 
X-ray), specific ones will be made depending on the diagnostic suspicion (Table 7) 
[20, 30].
2.6 Differential diagnosis of ischemic stroke
There are many conditions (vascular or nonvascular) that may simulate an 
acute ischemic stroke. One study reveals that 14% of patients that had presented 
with acute neurological deficits were falsely diagnosed with ischemic stroke and 
received thrombolytic medication. The reevaluation proved to be, in fact, a stroke 
mimic. The differential diagnosis may differ depending on the age of the patient. 
In general, in a young patient presenting with sudden focal deficit, the following 
should be taken into consideration: hemorrhagic stroke, cerebral venous throm-
bosis, complicated migraine, seizures, acute vestibular syndrome, central nervous 
system tumor or abscess, multiple sclerosis, myasthenia gravis, alcohol intoxication, 
drug or medication toxicity, hypo or hyperglycemia, dyselectrolytemia, uremia, 
hyperthyroidism, hepatic encephalopathy, hypertensive encephalopathy, Wernicke 
encephalopathy, cardiac syncope and psychiatric disorders [10, 31, 32].
2.7 Treatment and prognosis
The clinical presentation, treatment, and clinical outcome depend on the type 
and cause of stroke. After the etiology of stroke is identified, management and 
prevention are individualized [2].
The therapy of choice remains intravenous thrombolysis with recombinant 
tissue plasminogen activator. Young patients tend to have fewer complications, if 
the therapy is administered faster and the outcome is favorable. Bleeding risk is 
substantially decreased. The delay between presentation and therapy initiation is 
usually caused by difficulties in diagnosis [33].
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Clinical clue Suspicion
Fever Infection
Connective tissue disease
Vasculitis
Lymphadenopathy Lymphoma
Infection
History of asthma Churg Strauss syndrome
History of recent head 
trauma
Arterial dissection
In situ arterial thrombosis
Headache Hereditary endotheliopathy, retinopathy, nephropathy, and stroke (HERNS)
Cerebral autosomal dominant arteriopathy with subcortical infarcts and 
leukoencephalopathy
(CADASIL)
Reversible cerebral vasoconstriction syndrome (RCVS)
Arterial dissection
Vasculitis
Systemic lupus erythematosum (SLE)
Acroparesthesia Fabry disease
Erythema migrans Lyme disease
Oral/genital ulcers Syphilis
SLE
Behçet disease
Herpes simplex
Angiokeratomas Fabry disease
Erythema nodosum Connective tissue disease
Tuberculosis
Poststreptococcal infections
Sarcoidosis
Behçet disease
Butterfly erythema SLE
Splinter hemorrhages 
underneath the nail
Endocarditis
Raynaud syndrome Connective tissue disease
Neoplasia
Blood hyperviscosity
Needle puncture signs Drug use
Tattoos HIV infection
Hepatitis
Alopecia Systemic lupus erythematosus (SLE)
Temporal arteritis
Cerebral autosomal recessive arteriopathy with subcortical infarcts and 
leukoencephalopathy (CARASIL)
Xanthelasma Hyperlipidemia
Decreased vision Mitochondrial disease
HERNS
Pseudoxanthoma elasticum
Claude Bernard 
Horner Syndrome
Carotid dissection
Dry eyes Sjögren syndrome
Iritis Behçet disease
Roth spots Endocarditis
Table 6. 
Clinical clues in ischemic stroke in the young.
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Studies show that the mortality in young stroke patients is up to four times 
higher in the first 20 years after the stroke than healthy people [3]. It has also been 
observed that cardiac insufficiency and stroke severity are important mortality 
predictors [2].
Additional investigations
Blood/urine toxicology Drug use
Arterial blood gas analysis MELAS
Rheumatoid factor
Complement level
dsDNA antibodies
ANA antibodies
Anti Ro, anti La antibodies
Scl 70 antibody
Anticentromere antibody
Anticardiolipin antibodies
Cryoglobulins
Serum angiotensin-converting enzyme
Connective tissue disease/other 
rheumatic diseases
ANCA antibodies
Fluorescein angiography
Systemic angiitis
Electrophoresis Paraproteinemia
Hemoglobin electrophoresis Sickle cell disease
Specific tests for syphilis, tuberculosis, herpes, HIV, Lyme, and 
hepatitis
Infectious disease
D-dimers Thromboembolism
Protein S, Protein C, Factor V Leiden, antithrombin, 
prothrombin gene mutation
Coagulation abnormalities
Echocardiography Patent foramen ovale
Cardiomyopathy
Endocarditis
Holter electrocardiogram Atrial fibrillation
Lower extremity ultrasonography (in patients with PFO) Deep vein thrombosis
Coombs test Hematologic abnormalities
Bone marrow biopsy Hematologic abnormalities
Cerebrospinal fluid examination (cellularity, glucose, proteins, 
oligoclonal bands, and infectious agents)
Arterial/skin/muscle biopsy Giant cell arteritis
CADASIL
CARASIL
Mitochondrial disease
Brain biopsy Primary cerebral vasculitides
α-Galactosidase enzyme level Fabry disease
Homocysteine level Homocystinuria
Genetic tests CARASIL/CADASIL and others
Advanced imaging techniques Personalized, depending on clinical 
suspicion
Table 7. 
Specific additional investigations for young stroke etiology.
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Because we are referring to a younger, still employed population, the socioeco-
nomic burden cannot be neglected. We learn from studies that up to one third of 
patients who suffered an ischemic stroke remain unemployed even up to 8 years 
after the episode. This may be due to the disability or solely the consequence 
of depression. Depression following the stroke is a frequent find between this 
segment of patients, along with chronic fatigue and anxiety [3]. In addition, 
depression has been shown to also influence mortality [30]. Some other long-term 
consequences that have to be taken into consideration are chronic central pain, 
sexual dysfunction, cognitive impairment, and epileptic syndrome. Due to this 
multiple possible consequences, the patients’ approach should be multidisci-
plinary, including a neurologist, a psychologist or a psychiatrist, and an occupa-
tional therapist [3].
Another important aspect is the risk of recurrence. Cardioembolic strokes or 
patients suffering from atherosclerosis affecting the large vessels are the ones most 
at risk for recurrence [3].
2.8 Rehabilitation after stroke
The rehabilitation process of stroke victims is extremely complex. It is not lim-
ited only to the medical part of the process, but also includes social, economic, and 
vocational aspects. It is important to keep in mind that the patient rehabilitation 
should be achieved through a multidisciplinary approach, with a team of specialists 
from different domains of activity: physicians, nurses, physiotherapists, speech-
language therapists, social workers, and occupational therapists [34].
The methods used for rehabilitation are similar between the young and the 
elderly. It has been observed that younger people tend to achieve a full recovery 
after stroke more frequently and more rapidly and require institutionalization less 
frequently than older patients. The main predictors of full recovery after stroke are 
age and stroke severity. On the other hand, younger patients struggle more with 
adjustment issues, family stress, vocational issues, and depression. For this reason, 
rehabilitation in younger people should focus on issues regarding disease acceptance 
and community integration. It is of uttermost importance for these patients to be 
informed about their disease, about possible future consequences, including stroke 
recurrence. Including these patients in support groups of stroke victims of similar 
age would also be extremely useful [35].
The rehabilitation program can be performed in acute care hospitals, in different 
rehabilitation centers, or even at home. In absence of contraindications, rehabilita-
tion should begin as early as possible. Early mobilization, when possible, is also 
recommended in the first 18–24 hours. The process is individualized depending on 
patient’s disabilities and focuses on improving cognitive, motor, and speech skills. 
Motor rehabilitation includes different techniques to improve mobility, balance, sit-
to-stand, gait, and upper limb function and limit spasticity. Different fitness activi-
ties and recreational sports are encouraged in young people since there is a tendency 
to cease such activities after stroke. Somatosensory rehabilitation and speech 
therapy should also be included. Acupuncture may be useful for chronic fatigue. 
Noninvasive brain stimulation (NIBS) helps the process of neuroplasticity [36].
Regarding long-term results, studies show that the beneficial results of rehabili-
tation programs are maintained up to 1 year after the program is finalized [37].
A more modern and practical rehabilitation method is the StrokeBack project. 
The rehabilitation process can be done at home and uses telemedicine. The patients 
first learn the exercises with the help of a physiotherapist and then practice those 
exercises in the comfort of his own home. The patient’s progress is being monitored 
Ischemic Stroke
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and then receives feedback from his caregiver. The method has multiple advantages. 
Patients are more motivated because they receive constant feedback, and they 
have the tendency to exercise more, and as a result, their quality of life improves. 
Another beneficial aspect is that healthcare costs are diminished due to fewer hospi-
tal visits. This program would also be helpful especially given the current situation, 
the Covid-19 pandemic. Patients would still continue their rehabilitation process at 
home for an indefinite period [38].
2.9 Prevention of stroke in young adults
Primary and secondary stroke prevention is identical both for the young and 
for the elderly [2]. Prevention focuses primarily on classical cardiovascular risk 
factors: hypertensions, dyslipidemia, and diabetes. Drug use should be actively 
discouraged, and a healthy lifestyle promoted: lose weight, exercise regularly, cease 
smoking, reduce alcohol consumption, and eat more fresh fruits and vegetables [8]. 
In addition, depending on the etiology, prevention should be individualized and 
specific measures should be taken.
Another important aspect is raising awareness regarding stroke’s most com-
mon signs and symptoms. Presentation to hospitals is usually delayed because of 
improper identification. Patients or bystanders fail to recognize the symptoms 
and signs of stroke. This is due to the fact that stoke is still considered an illness 
affecting exclusively the elderly. As a consequence, education programs should be 
implemented in schools, and awareness campaigns should be created [39, 40].
3. Conclusions
Due to the increasing incidence and the possibility of it leaving long-term 
consequences, ischemic stroke can be considered a public health concern. Although 
less suspected in the young, these patients require early identification and must 
receive rapid medical care. For this reason, awareness campaigns should be devel-
oped. People should know that stroke can occur at any age and be aware of its most 
important signs and symptoms.
The etiology of ischemic stroke in the young differs from that found in the 
elderly. The possible causes are multiple, including rare genetic ones. But unfortu-
nately, very often, the causes remain unidentified. One possible explanation of this 
phenomenon is that there are currently no specific guidelines for stroke manage-
ment in young patients. For this reason, for the diagnosis, treatment, and subse-
quently secondary prevention of ischemic stroke, a series of universal management 
guidelines should be developed with priority.
Keeping in mind that stroke occurs at people of young age, with long-life spans 
ahead, the prognosis of patients after the ischemic event is important to be evalu-
ated. Consequently, developing universal prognosis scores could be extremely 
valuable. Another particularly important aspect would be determining the risk of 
recurrence.
Due to increased prevalence of classic cardiovascular risk factors at younger 
age, physicians should also focus on primary and secondary prevention, actively 
counseling patients regarding these risk factors, and offer support in their attempt 
to gradually change their lifestyle. Patients should be advised to give up smoking, 
exercise regularly, lose weight, rest properly, and reduce alcohol consumption.
Such measures and initiatives should ease the diagnosis process of determining 
the cause of stroke in young patients, help better manage the case, and reduce the 
recurrence rate.
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